Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1994-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.38.2.217PMID 8192446PMCID PMC284429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary disposition of antimicrobial agents: methodological considerations

  1992cited by this paper
• Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection

  1992influential reference
• MINIREVIEWS Pulmonary Disposition ofAntimicrobial Agents: Methodological Considerations

  1992cited by this paper
• Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

  1992cited by this paper
• Stimulation with cytokines enhances penetration of azithromycin into human macrophages

  1991cited by this paper
• Clinical toleration and safety of azithromycin.

  1991cited by this paper
• Spectrum of activity of azithromycin

  1991cited by this paper
• Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia

  1991cited by this paper
• Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol.

  1990cited by this paper
• The pharmacokinetics of azithromycin in human serum and tissues.

  1990cited by this paper
• The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.

  1990cited by this paper
• Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.

  1990cited by this paper
• Intracellular accumulation of azithromycin by cultured human fibroblasts

  1990cited by this paper
• In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia

  1990cited by this paper
• Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.

  1990cited by this paper
• NewDirections forMacrolide Antibiotics: Structural Modifications andInVitro Activity

  1989cited by this paper
• Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes.

  1989influential reference
• In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

  1989influential reference
• WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages

  1989cited by this paper
• New directions for macrolide antibiotics: structural modifications and in vitro activity

  1989cited by this paper
• Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.

  1988cited by this paper
• Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.

  1987cited by this paper
• Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution

  1987influential reference
• Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms

  1987cited by this paper
• Influence of growth temperature on virulence of Legionella pneumophila

  1987cited by this paper
• Antimicrobial therapy of experimentally induced Legionnaires' disease in guinea pigs.

  1984influential reference
• The kinetics of early inflammatory events during experimental pneumonia due to Legionella pneumophila in guinea pigs.

  1983cited by this paper
• Membrane flow during pinocytosis. A stereologic analysis

  1976cited by this paper
• Commentary. Lysosomotropic agents.

  1974cited by this paper
• Microbioassay ofAntimicrobial Agents

  1970cited by this paper
• Microbioassay of antimicrobial agents.

  1970cited by this paper

• Case Commentary: A herculean effort for Mycobacterium heraklionense—localized azithromycin bead pharmacokinetics

  2025cites this paper
• Quantitative Raman Chemical Imaging of Intracellular Drug-Membrane Aggregates and Small Molecule Drug Precipitates In Cytoplasmic Organelles.

  2023cites this paper
• Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish

  2021cites this paper
• Development and validation of a sensitive LC-MS/MS method for the quantitation of IMB-YH-4py5-2H, an antituberculosis candidate, and its application to the pharmacokinetic study

  2020cites this paper
• Azithromycin Phenotypic versus Clinical Resistance

  2019cites this paper
• An Expandable Mechanopharmaceutical Device (1): Measuring the Cargo Capacity of Macrophages in a Living Organism

  2018cites this paper
• REVIEW: COMPERATIVE PHARMACOKINETIC STUDY OF AZITHROMYCIN AND ROXITHROMYICIN IN ALTERED GASTRIC MOTILITY ON WISTAR RATS

  2018cites this paper
• Retrospective analysis of azithromycin versus fluoroquinolones for the treatment of legionella pneumonia.

  2014cites this paper
• Maternal Intravenous Administration of Azithromycin Results in Significant Fetal Uptake in a Sheep Model of Second Trimester Pregnancy

  2014cites this paper
• The Guinea pig model of legionnaires' disease.

  2013cites this paper
• KUCERS ' THE USE OF ANTIBIOTICS A CLINICAL REVIEW OF ANTIBACTERIAL , ANTIFUNGAL , ANTIPARASITIC AND ANTIVIRAL DRUGS VO , LUME

  2011cites this paper
• The role of azithromycin in patients with cystic fibrosis.

  2010cites this paper
• A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo.

  2010cites this paper
• Antibiotic Prophylaxis Improves Ureaplasma-Associated Lung Disease in Suckling Mice

  2009cites this paper
• Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits.

  2007cites this paper
• Immunomodulatory Effects of Macrolide Antibiotics in Respiratory Disease

  2007cites this paper
• Pharmacokinetics and tissue tolerance of azithromycin after intramuscular administration to rabbits.

  2006cites this paper
• Legionellosis

  2005cites this paper
• Antibioticakeuze bij een Legionella-infectie

  2005cites this paper
• Guías para el manejo de la neumonía comunitaria del adulto que precisa ingreso en el hospital

  2005cites this paper
• Pharmacokinetics of azithromycin after i.v. and i.m. administration to sheep.

  2005cites this paper
• Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.

  2005cites this paper
• Phagozytose-assoziierte Rezeptoren bei der Legionellen-Pathogenese

  2003cites this paper
• Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.

  2003cites this paper
• Activities of Tigecycline (GAR-936) against Legionella pneumophila In Vitro and in Guinea Pigs with L. pneumophila Pneumonia

  2003cites this paper
• Antibiotics and pharmacogenomics.

  2003cites this paper
• Cellular accumulation of macrolide antibiotics. Intracellular bioactivity

  2002cites this paper
• Tosufloxacin の in vitro 抗 Legionella pneumophila 活性およびモルモット実験的肺炎に対する治療効果

  2002cites this paper
• In Vitro Activity of ABT-773 againstLegionella pneumophila, Its Pharmacokinetics in Guinea Pigs, and Its Use to Treat Guinea Pigs with L. pneumophila Pneumonia

  2001cites this paper
• Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes.

  2001cites this paper
• In Vitro Activity of Gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and Its Pharmacokinetics in Guinea Pigs with L. pneumophila Pneumonia

  2001cites this paper
• BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.

  2001cites this paper
• Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.

  2001cites this paper
• Chapter 34 – The Guinea-pig Model of Legionnaires' Disease

  1999cites this paper
• Leading article The treatment of Legionnaires' disease

  1999cites this paper
• The treatment of Legionnaires' disease.

  1999cites this paper
• Erythromycin Inhibits Transcriptional Activation of NF-κB, but not NFAT, through Calcineurin-Independent Signaling in T Cells

  1999cites this paper
• Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection

  1999cites this paper
• Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection.

  1999cites this paper
• Antibacterial Effects of Levofloxacin, Erythromycin, and Rifampin in a Human Monocyte System againstLegionella pneumophila

  1998cites this paper
• Macrolide antibiotics in food-animal health.

  1997cites this paper
• In vitro and in vivo evaluation of the antimicrobial activity of azithromycin againstLegionella species

  1997cites this paper
• Rationale for the Use of Azithromycin as Mycobacterium avium Chemoprophylaxis

  1997cites this paper
• Intracellular bioactivity of macrolides.

  1996cites this paper
• Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia

  1996cites this paper
• Pharmacokinetics of antimicrobial agents in the respiratory tract.

  1996cites this paper
• [Azithromycin, pharmacodynamic evaluation in animal models].

  1995cites this paper
• Review of azithromycin activity against Legionella spp.

  1995cites this paper
• Antimicrobial chemotherapy for legionnaires' disease: a review.

  1995cites this paper
• Section Review Anti-infectives: Recent developments in 14- and 15-membered macrolides

  1995cites this paper
• [Azithromycin: critical points].

  1995cites this paper